November 13, 2026 · Journal of the American Society of Nephrology : JASN · DOI: 10.1681/ASN.0000001313

Association of Second Anti-hypertensive Agent with Outcomes in People with CKD on ACEi/ARB Therapy.

Listen to this summary

This target trial emulation using Veterans Health Administration data asked which second antihypertensive added to ACEi/ARB therapy is linked to better outcomes in people with non-dialysis CKD, since guidelines are silent on this choice. Among 150,369 patients, adding a thiazide diuretic was associated with lower risks of cardiovascular events, death, and kidney outcomes than adding a calcium channel blocker, β-blocker, or loop diuretic. These observational findings suggest thiazides may be a preferred add-on, though residual confounding is possible.

L Parker Gregg, Aaron Perkins, Hui Yang, Christine Vu, Vijay Nambi, Wolfgang C Winkelmayer, S Susan Hedayati, Sankar D Navaneethan, Carlos A Alvarez

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play